NCT01625871View on ClinicalTrials.gov

Artemether/Lumefantrine and Vivax Malaria

PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Vivax Malaria
Interventions
DRUG

tablets artemether/lumefantrine

six doses of oral tablets of artemether/lumefantrine

Trial Locations (1)

249

Kassala, Kassala

All Listed Sponsors
collaborator

University of Kassala, Sudan

OTHER

lead

University of Khartoum

OTHER

NCT01625871 - Artemether/Lumefantrine and Vivax Malaria | Biotech Hunter | Biotech Hunter